期刊文献+

无症状型原发性甲状旁腺功能亢进症临床特点分析 被引量:11

The clinical characteristics of asymptomatic primary hyperparathyroidism in Peking Union Medical College Hospital
暂未订购
导出
摘要 目的随着血钙水平筛查的普及,西方国家原发性甲状旁腺功能亢进症(PHPT)的多数患者表现为无症状型或轻症HPT(aPHPT),而国内文献报告的PHPT患者大多具有典型临床表现。本研究旨在通过分析北京协和医院诊断的无症状型PHPT患者的临床资料,总结我院无症状型PHPT的特点。方法 1958年~2006年5月在北京协和医院经生化检查、手术病理证实的散发性PHPT患者278例,参照NIH共识标准,其中18例诊断为aPHPT,与260例经典型PHPT(cPHPT)患者进行比较。病历资料采用回顾性分析。测定PHPT患者的血总钙(TCa)、游离钙(ICa)、磷(P)、碱性磷酸酶(AKP)、甲状旁腺素(PTH)、及24小时尿Ca、P水平,部分患者采用DXA测定腰椎、股骨上段骨密度(BMD)。采用SPSS11.5软件进行统计分析。结果 (1)一般情况及生化指标:aPHPT组年龄(54.2±18.8岁)大于cPHPT组(41.1±15.1岁),P=0.001。aPHPT组及cPHPT组术前血AKP中位数分别为96.0(79.3,335.8)IU/L和467.5(197.0,1121.7)IU/L,有显著差异(P<0.001),其他生化指标在两组间未发现显著性差异。(2)骨密度:aPHPT组(n=8)L_(2-4) BMD的T值、Z值分别为-1.35±1.78和-0.74±1.28,cPHPT组(n=89)L_(2-4) BMD的T值、Z值分别为-2.74±1.48和-1.97±1.68,均有显著性差异(P=0.014,0.047)。(3)手术结果:aPHPT组中11例(61.1%)为腺瘤,7例(38.9%)为增生,均为良性病变;cPHPT组中197例(75.8%)为腺瘤,44例(16.9%)为增生,19例(7.3%)为腺癌,两组分布有显著差异(P=0.013)。aPHPT组、cPHPT组肿瘤直径分别为2.24±1.12cm和2.82±1.20cm,P=0.050。结论与经典型PHPT相比较,我院的无症状型PHPT患者诊断年龄较大,术前血AKP水平升高、腰椎骨密度降低不如经典HPT明显,病变甲状旁腺直径较小,病理类型均为良性且增生比例较高。无症状PHPT患者中大部分存在骨量减少甚至骨质疏松,但需要更大的样本量进一步研究。 Objective In western countries where the multichannel screening of serum calcium is readily availa- ble, most of the patients of primary hyperparathyroidism (PHPT) present asymptomatic (aPHPT). In this study, we ana- lyzed the clinical data of asymptomatic PHPT patients diagnosed in Peking Union Medical College Hospital (PUMCH) to summarize their clinical characteristics. Methods From 1958 to 2006, 278 patients were diagnosed as sporadic PHPT according to biochemical markers and pathology, among which 18 cases were classified as asyrnptomatic PHPT (aPHPT) based on NIH consensus. The clinical data of patients of aPHPT and classical PHPT (cPHPT) was retrospectively ana- lyzed. The biochemical markers including blood TCa, ICa, P, AKP, PTH and 24h urinay Ca, P levels were measured. BMD of L2-4 and proximal femurs was measured by DXA. SPSS 11.5 software were used for statistical analysis. Results ( 1 ) The age of diagnosis was significantly older in aPHPT than cPHPT patients (54. 2± 18.8 years vs 41.1± 15.1 years, P = 0. 001 ). The pre-surgical serum AKP levels were significantly higher in cPHPT group than in aPHPT group ( median 96. 0IU/L vs 467.5IU/L, P 〈 0. 001 ). The T-scores ( - 2. 74 ± 1.48 vs - 1.35 ± 1.78, P -- 0. 014 ) and Z- scores ( - 1.97 ± 1.68 vs - O. 74 ± 1.28, P = 0. 047 ) of L2.4 were significantly lower in cPHPT group than in aPHPT group. Eleven cases (61.1%) and 7 cases (38. 9% ) of aPtlPT were adenoma and hyperplasia, respectively. 197 cases (75. 8% ), 44 cases ( 16.9% ) and 19 cases (7. 3% ) of cPHPT were adenoma, hyperplasia and carcinoma, respective- ly. The distribution of the pathological types was significantly different between the two groups (P --0. 013 ). The diame- ters of tumors in aPHPT group and cPHPT group were 2. 24 ± 1.12cm and 2. 82 ± 1.20cm, respectively, P = 0. 050. Conclusion In the present study, compared to classical PHPT patients, the age of diagnosis was older, elevation of pre- surgical serum AKP and decrease in lumbar BMD were less significant in aPHPT group. The diameters of tumor were smaller and the ratio of hyperplasia was higher in aPHPT group than in cPHPT group. The majority of patients with aPHPT presented osteopenia or osteoporosis. Further prospective studies with larger sample size are necessary.
出处 《中华骨质疏松和骨矿盐疾病杂志》 2010年第1期18-22,共5页 Chinese Journal Of Osteoporosis And Bone Mineral Research
关键词 原发性甲状旁腺功能亢进症 无症状型 经典型 临床特点 primary hyperparathyroidism asymptomatic classical clinical characteristics
  • 相关文献

参考文献11

  • 1闫双通,田慧,李春霖,宗文漪,邵迎红,钟文雯,龚燕平.中老年人群原发性甲状旁腺功能亢进症患病率初步调查[J].中华内科杂志,2007,46(8):651-653. 被引量:10
  • 2韩恩昆,刘自宽,朱理玮,齐骏,王鹏志,高硕,周荫保,白人驹.原发性甲状旁腺机能亢进症101例分析[J].中国实用外科杂志,1998,18(3):147-149. 被引量:29
  • 3余卫,秦明伟,徐苓,田均平,邢小平,孟迅吾,曹坚,严洪珍,葛秦生.正常人腰椎骨密度变化(附445例双能X线骨密度仪测量分析)[J].中华放射学杂志,1996,30(9):625-629. 被引量:58
  • 4孟迅吾,邢小平,刘书勤,詹志伟,周学瀛,刘怀成,史轶蘩,沙利进,余卫,解毓章.原发性甲状旁腺功能亢进症的诊断(附134例分析)[J].中国医学科学院学报,1994,16(1):13-19. 被引量:43
  • 5Melton LJ.The epidemiology of primary hyperparathyroidism in North America. Journal of Bone and Mineral Research . 2002
  • 6Bilezekian JP,Rubin M,Silverberg SJ.Asyptomatic primary hyperparathyroidism. Arq Bras Endocrinol Metab . 2006
  • 7Mithal,A,Bandeira,C,Meng,XW,Bilezikizn,JP,Marcus,R,Levine,M.Clinical presentation of primary hyperparathyroidism: India, Brazil and China. The Parathyroids: Basic and Clinical Concepts . 2001
  • 8Rao,DS,Agarwal,G,Talpos,GB.Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism:a global perspective. Journal of Bone and Mineral Research . 2002
  • 9SJ Silverberg,EM Lewiecki,L Mosekilde.Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. The Journal of Clinical Endocrinology . 2009
  • 10Bilezikian JP,Potts JT.Asymptomatic primary hyperparathyroidism: New issues and new questions-Bridging the past with the future. Journal of Bone and Mineral Research . 2002

二级参考文献20

共引文献134

同被引文献62

  • 1周建平,李晓莉,董明,郭克建,田雨霖.我国原发性甲状旁腺功能亢进症的误诊情况分析[J].中国现代医学杂志,2006,16(7):1040-1042. 被引量:50
  • 2黄东瑾.老年原发性甲状旁腺功能亢进症误诊分析[J].广东医学,2006,27(10):1594-1594. 被引量:1
  • 3邢小平,王鸥,孟迅吾,夏维波,李梅,姜艳,韩桂艳,胡莹莹,刘怀成.北京与纽约原发性甲状旁腺功能亢进症临床表现的比较[J].诊断学理论与实践,2006,5(6):483-486. 被引量:24
  • 4Melton LJ 3rd. The epidemiology of primary hyperpamthyroidism in North America [J] J Bone Miner Res, 2002, 17 Suppl 2: N12-N17.
  • 5Mariani G, Gulec SA, Rubello D, et al. Preoperative localization and radioguided parathyroid surgery [ J]. J Nucl Med, 2003, 44(9): 1443-1458.
  • 6Bilezikian JP, Rubin M, Silverberg SJ. Asymptomatic primary hyperparathyroidism [J]. Arq Bras Endocrinol Metabol, 2006, 50(4): 647-656.
  • 7Bilezikian JP, Ports JT Jr. Asymptomatic primary hyperparathy- roidism: new issues and new questions-bridging the past with the future [J]. J Bone Miner Res, 2002, 17 Suppl 2: N57-N67.
  • 8Starker LF, Mahajan A, Bj6rklund P, et al. 4D parathyroid CT as the initial localization study for patients with de novo primary hyperparathyroidism [J]. Ann Surg Oncol, 2011, 18(6): 1723- 1728. doi: 10. 1245/s10434-010-1507-0.
  • 9Arora S, Balash PR, Yoo J, et al. Benefits of surgeon-performed ultrasound for primary hyperparathyroidism [J]. Langenbecks Arch Surg, 2009, 394(5): 861-867.
  • 10Rubello D, Massaro A, Cittadin S, et al. Role of 99~"Tc-sestamibi SPECT in accurate selection of primary hyperparathyroid patients for minimally invasive radio-guided surgery [J]. Eur J Nucl Med Mol Imaging, 2006, 33(9): 1091-1094.

引证文献11

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部